Structural Heart Disease Program
The Structural Heart Disease Program is a collaborative effort providing innovative treatment solutions for patients with complex structural heart disease. Our team is comprised of physicians and health care providers from multiple specialties working together to treat these complex patients using methods that are less invasive than open heart surgery.
Learn more about our collaborative process in this video.
Appointments & Referrals
Physician referral required.
Email inquiries to TAVRinformation@swedish.org.
Structural Heart Disease Program Referral Form
We offer the following valve treatments as part of our portfolio of procedures in the structural heart disease program:
Transcatheter Aortic Valve Replacement (TAVR
An innovative therapy for patients with severe, symptomatic aortic stenosis who are non-operable or deemed high risk for traditional open heart surgery.
Swedish is one of the premier hospitals performing this procedure in the region, offering multiple commercial and investigational valves to meet all patient needs.
A percutaneous alternative for patients who are not optimal candidates for mitral valve repair or replacement.
In October 2013, the MitraClip was commercially approved for patients with degenerative mitral regurgitation.
The Swedish Structural Heart Disease program has been working with the MitraClip research and development program since 2003, with the first implant performed in the Northwest in 2004.
We are currently enrolling patients in the COAPT trial using the MitraClip for patients with moderate to severe functional mitral regurgitation.